Matinas BioPharma Holdings, Inc. Gains 22.15%

Fri, Oct 21, 2022 at 07:32 PM
Matinas BioPharma Holdings, Inc. Gains 22.15%

Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT) soared at $0.85, a gain of 22.1%. On Fri, Oct 21, 2022, MTNB:NYSEMKT hit a New 2-Week High of $0.85. The stock appeared on our News Catalysts scanner on Fri, Oct 21, 2022 at 08:17 AM in the 'MISCELLANEOUS' category. From Fri, Oct 07, 2022, the stock recorded 50.00% Up Days and 54.55% Green Days

About Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT)

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company engaged in identifying & developing safe and effective broad spectrum therapeutics for the treatment of serious and life-threatening infections.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.